Gait-specific Optimization of Deep Brain Stimulation Using Connectomic Targets
Calvin Howard1, Savir Madan1, Nanditha Rajamani1, Lauren Hart2, Ella Gray Settle1, Martin Reich3, Andreas Horn4, Michael Fox5
1Harvard Medical School, 2Brigham and Women's, 3University of Wurzburg, 4University of Cologne, 5Brigham and Women's Hospital / Harvard Medical School
Objective:

Test whether symptom-specific connectomic targets for gait dysfunction can be translated into actionable DBS settings using an optimization algorithm.

Background:

Symptom-specific deep brain stimulation (DBS) targets (functional networks or fiber tracts) derived from connectomics are compelling, but it is unclear how to translate them into DBS parameters. Here, we develop a machine learning algorithm which translates the symptom-specific targets into DBS parameters. We investigate this using gait dysfunction in Parkinson's and evaluate two recent gait-specific targets. 

Design/Methods:

We built an optimization algorithm that individualizes each electrode’s parameters to maximize overlap of the DBS stimulation with symptom-specific targets. We used two retrospective cohorts (training n=44; test n=100) as well as a recent gait-specific brain network and gait-specific fiber tract. We developed a hand-crafted optimization algorithm and tuned it on the training cohort, then tested it using the held-out test cohort. We assessed if: 1) the algorithm provided significantly different DBS parameters than best clinical settings, 2) if being closer to theoretically optimal DBS parameters was associated with better gait scores, and 3) if the algorithm provided useful settings in a small prospective pilot of 4 patients.

Results:

Optimizer-suggested programs showed markedly greater engagement of both targets compared to the best clinical settings (functional: t=27.3, p<0.0001; tract: t=17.0, p<0.0001). Further, increased similarity to the 'gait-optimal' settings was associated with gait improvement one year after DBS for both the functional target (p=0.37, p<0.0001) and the fiber tract target (p=0.52, p<0.0001). Finally, in a prospective feasibility step (n=4), reprogramming to the optimizer-derived settings improved gait without adverse effects. 

Conclusions:
Using gait-specific brain networks and fiber tracts, we find connectome-derived symptom-specific targets can be translated into symptom-specific DBS settings. These symptom-specific DBS settings deviate significantly from standard DBS settings and may be associated with therapeutic benefit in challenging symptoms like gait dysfunction.
10.1212/WNL.0000000000217547
Disclaimer: Abstracts were not reviewed by Neurology® and do not reflect the views of Neurology® editors or staff.